[Form 4] Rocket Lab Corp Insider Trading Activity

Rhea-AI Filing Summary

Rocket Lab Corp (RKLB) CEO and Director Peter Beck reported equity awards and related share sales. On 11/15/2025, he was granted 132,426 restricted stock units (RSUs)$0.0. These RSUs vest over time, with 1/16 vesting on November 22, 2025 and 1/16 on each March 1, May 22, August 22 and November 22 thereafter, subject to his continuous service.

On 11/24/2025, Beck sold 4,707, 14,073 and 77 common shares in three separate transactions as sell-to-cover sales to satisfy tax withholding related to RSU vesting. The weighted average sale prices were $40.0247, $40.8576 and $41.3495, each executed in multiple trades within specified price ranges. After these transactions, he directly owned 902,942 Rocket Lab shares and was also reported as an indirect beneficial owner of 2,500,000 shares held by a family trust.

11/25/2025 - 07:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beck Peter

(Last) (First) (Middle)

3881 MCGOWEN STREET

(Street)

LONG BEACH CA 90808

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rocket Lab Corp [ RKLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/15/2025		A		132,426(1)	A	$0.0	921,799	D
Common Stock	11/24/2025		S		4,707(2)	D	$40.0247(3)	917,092	D
Common Stock	11/24/2025		S		14,073(2)	D	$40.8576(4)	903,019	D
Common Stock	11/24/2025		S		77(2)	D	$41.3495(5)	902,942	D
Common Stock								2,500,000	I	by Trust(6)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to Peter Beck under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan. Such RSUs will vest as follows: 1/16 of the RSUs will vest on November 22nd, 2025 and 1/16 of the RSUs will vest on each March 1st, May 22nd, August 22nd or November 22nd thereafter, in each case subject to Peter Beck's continuous service through each applicable vesting date.

2. Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

3. The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $39.3400 to $40.3300 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $40.3400 to $41.3300 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $41.3400 to $41.4200 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. These shares are held directly by the Trust, a family trust settled by Peter Beck and Kerryn Beck. Peek Street Equatorial Trustee Limited (the "Trustee") is the trustee of the Trust and each of Peter Beck, Kerryn Beck and Warren Butler serve as a director of the Trustee with shared voting and investment control of the shares and, as a result, the Trustee and each such individual is deemed to be an indirect beneficial owner of these shares. Each Reporting Person disclaims beneficial ownership of these shares, except to the extent, if any, of his, her or its pecuniary interest therein, and the filing of this Form 4 is not an admission that any Reporting Person is the beneficial owner of these shares.

	By: /s/Arjun Kampani, as Attorney-in-Fact For: Peter Beck	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Rocket Lab (RKLB) CEO Peter Beck report in this Form 4?

Peter Beck reported receiving 132,426 RSUs on 11/15/2025 under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan and several related common stock sales on 11/24/2025 to cover taxes from RSU vesting.

How do Peter Beck’s new RSUs for Rocket Lab (RKLB) vest?

The 132,426 RSUs will vest as follows: 1/16 on November 22, 2025 and 1/16 on each March 1, May 22, August 22 and November 22 thereafter, in each case subject to his continuous service.

How many Rocket Lab (RKLB) shares did Peter Beck sell and at what prices?

On 11/24/2025, Beck sold 4,707, 14,073 and 77 common shares in three transactions with weighted average prices of $40.0247, $40.8576 and $41.3495, respectively. Each sale was executed in multiple trades within stated price ranges.

Why were Rocket Lab (RKLB) shares sold in these transactions?

The filing states the common shares sold on 11/24/2025 were part of sell-to-cover transactions used to satisfy applicable tax withholding obligations arising from the vesting and settlement of previously granted RSUs.

How many Rocket Lab (RKLB) shares does Peter Beck beneficially own after these transactions?

Following the reported transactions, Peter Beck directly owned 902,942 Rocket Lab common shares and was also reported as an indirect beneficial owner of 2,500,000 shares held by a family trust.

What is the role of the family trust in Peter Beck’s Rocket Lab (RKLB) holdings?

The filing notes that 2,500,000 Rocket Lab shares are held by a family trust settled by Peter and Kerryn Beck. A corporate trustee, with Peter Beck and others as directors, has shared voting and investment control, and each person is deemed an indirect beneficial owner of these shares, subject to their pecuniary interest.